RJA
HOLX

Raymond James & Associates’s Hologic HOLX Stock Holding History

Raymond James & Associates’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$25.3M Sell
310,905
-21,328
-6% -$1.71M 0.02% 698
2024
Q2 		$24.7M Sell
332,233
-37,282
-10% -$2.79M 0.02% 671
2024
Q1 		$28.8M Buy
369,515
+92,635
+33% +$6.89M 0.02% 611
2023
Q4 		$19.8M Buy
276,880
+24,867
+10% +$1.73M 0.01% 745
2023
Q3 		$17.5M Buy
252,013
+7,407
+3% +$560K 0.01% 741
2023
Q2 		$19.8M Buy
244,606
+15,400
+7% +$1.26M 0.02% 694
2023
Q1 		$18.5M Sell
229,206
-9,662
-4% -$778K 0.02% 718
2022
Q4 		$17.9M Sell
238,868
-30,778
-11% -$2.19M 0.02% 722
2022
Q3 		$17.4M Buy
269,646
+914
+0.3% +$63.3K 0.02% 674
2022
Q2 		$18.6M Buy
268,732
+7,095
+3% +$527K 0.02% 651
2022
Q1 		$20.1M Sell
261,637
-14,247
-5% -$1.02M 0.02% 702
2021
Q4 		$21.1M Sell
275,884
-17,071
-6% -$1.25M 0.02% 713
2021
Q3 		$21.6M Sell
292,955
-38,981
-12% -$2.92M 0.02% 661
2021
Q2 		$22.1M Buy
331,936
+75,876
+30% +$5.07M 0.02% 666
2021
Q1 		$19M Buy
256,060
+63,888
+33% +$4.85M 0.02% 692
2020
Q4 		$14M Sell
192,172
-138
-0.1% -$9.74K 0.02% 777
2020
Q3 		$12.8M Buy
192,310
+87,587
+84% +$5.54M 0.02% 736
2020
Q2 		$5.97M Buy
104,723
+27,892
+36% +$1.37M 0.01% 1082
2020
Q1 		$2.7M Buy
76,831
+18,191
+31% +$866K ﹤0.01% 1406
2019
Q4 		$3.06M Sell
58,640
-143,479
-71% -$7.14M ﹤0.01% 1566
2019
Q3 		$10.2M Buy
202,119
+8,729
+5% +$430K 0.01% 856
2019
Q2 		$9.29M Buy
193,390
+62,495
+48% +$2.89M 0.01% 889
2019
Q1 		$6.33M Buy
130,895
+11,333
+9% +$511K 0.01% 1062
2018
Q4 		$4.91M Buy
119,562
+6,158
+5% +$253K 0.01% 1115
2018
Q3 		$4.65M Buy
113,404
+12,388
+12% +$501K 0.01% 1260
2018
Q2 		$4.01M Buy
101,016
+12,191
+14% +$469K 0.01% 1330
2018
Q1 		$3.32M Buy
88,825
+14,471
+19% +$585K 0.01% 1390
2017
Q4 		$3.18M Buy
74,354
+12,068
+19% +$481K 0.01% 1394
2017
Q3 		$2.29M Sell
62,286
-29,195
-32% -$1.18M ﹤0.01% 1558
2017
Q2 		$4.15M Sell
91,481
-71,657
-44% -$3.16M 0.01% 1119
2017
Q1 		$6.94M Sell
163,138
-38,148
-19% -$1.56M 0.02% 869
2016
Q4 		$8.08M Buy
201,286
+19,766
+11% +$763K 0.02% 733
2016
Q3 		$7.05M Buy
181,520
+144,635
+392% +$5.46M 0.02% 770
2016
Q2 		$1.28M Buy
36,885
+16,708
+83% +$579K ﹤0.01% 1600
2016
Q1 		$696K Sell
20,177
-277
-1% -$9.66K ﹤0.01% 1862
2015
Q4 		$791K Sell
20,454
-11,161
-35% -$434K ﹤0.01% 1756
2015
Q3 		$1.24M Sell
31,615
-7,108
-18% -$282K 0.01% 1485
2015
Q2 		$1.47M Sell
38,723
-8,045
-17% -$282K 0.01% 1510
2015
Q1 		$1.54M Sell
46,768
-14,823
-24% -$455K 0.01% 1397
2014
Q4 		$1.65M Buy
61,591
+16,536
+37% +$427K 0.01% 1276
2014
Q3 		$1.1M Buy
45,055
+6,389
+17% +$161K 0.01% 1444
2014
Q2 		$980K Buy
38,666
+263
+0.7% +$6.15K 0.01% 1506
2014
Q1 		$826K Sell
38,403
-1,761
-4% -$38K 0.01% 1529
2013
Q4 		$898K Sell
40,164
-20,641
-34% -$455K 0.01% 1386
2013
Q3 		$1.26M Sell
60,805
-9,043
-13% -$192K 0.01% 1122
2013
Q2 		$1.35M Buy
+69,848
New +$1.46M 0.01% 1019

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Raymond James & Associates's HOLX Position: Q3 2024 in Review

Raymond James & Associates reduced its Hologic (HOLX) stake by 6.4% in Q3 2024, selling an estimated $1.71M and leaving 310,905 shares worth $25.3M. The position accounts for 0.02% of the portfolio, ranked #698.

Raymond James & Associates first reported a position in HOLX in Q2 2013 and has held it in 46 quarters since. The position peaked at $28.8M in Q1 2024. 727 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Raymond James & Associates held 310,905 shares of Hologic worth $25.3M as of Q3 2024.
  • Raymond James & Associates sold 21,328 Hologic shares in Q3 2024, an estimated $1.71M.
  • Hologic made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #698 holding.
  • Raymond James & Associates first reported a position in Hologic in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Hologic position peaked at $28.8M in Q1 2024.
  • 727 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.